CW
ABBV icon

Connectus Wealth’s AbbVie ABBV Stock Holding History

Connectus Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$4.63M Sell
25,430
-48,070
-65% -$8.28M 0.13% 128
2023
Q4 		$11.4M Buy
73,500
+3,970
+6% +$579K 0.23% 98
2023
Q3 		$10.4M Buy
69,530
+11,042
+19% +$1.62M 0.23% 101
2023
Q2 		$7.9M Buy
58,488
+2,415
+4% +$354K 0.18% 111
2023
Q1 		$8.95M Buy
56,073
+23,351
+71% +$3.57M 0.22% 104
2022
Q4 		$5.3M Sell
32,722
-2,189
-6% -$336K 0.13% 139
2022
Q3 		$4.69M Sell
34,911
-546
-2% -$78.3K 0.1% 186
2022
Q2 		$5.44M Sell
35,457
-201,077
-85% -$30.7M 0.12% 144
2022
Q1 		$32.1M Sell
236,534
-6,354
-3% -$923K 1.02% 25
2021
Q4 		$33M Buy
+242,888
New +$28.7M 1.28% 17

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Connectus Wealth's ABBV Position: Q1 2024 in Review

Connectus Wealth reduced its AbbVie (ABBV) stake by 65% in Q1 2024, selling an estimated $8.28M and leaving 25,430 shares worth $4.63M. The position accounts for 0.13% of the portfolio, ranked #128.

Connectus Wealth first reported a position in ABBV in Q4 2021 and has held it in 10 quarters since. The position peaked at $33M in Q4 2021. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Connectus Wealth held 25,430 shares of AbbVie worth $4.63M as of Q1 2024.
  • Connectus Wealth sold 48,070 AbbVie shares in Q1 2024, an estimated $8.28M.
  • AbbVie made up 0.13% of Connectus Wealth's portfolio in Q1 2024, its #128 holding.
  • Connectus Wealth first reported a position in AbbVie in Q4 2021 and has held it in 10 quarters since.
  • Connectus Wealth's AbbVie position peaked at $33M in Q4 2021.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Connectus Wealth's 13F filing for Q1 2024, filed 14 May 2024.